Tag: biopsy

We want to draw particular attention to a branch of AI called machine learning. When software is specifically “trained” to recognize imaging features, it can “… provide better standardization and consistency in identifying prostate lesions and enhance prostate carcinoma management.” One of the benefits is increased efficiency for busy radiologists who interpret MRI results and write reports. More importantly, however, is... keep reading

In September, 2018 we posted a blog on this promising news of the IsoPSA blood test for prostate cancer (PCa). Then, in October 2019, the FDA granted breakthrough device designation to the test, in order to work closely with the manufacturer to expedite approval. This move sprang from... keep reading

When it comes to spending money, you have choices. According to wealthfit.com, “Whether you spend 10 seconds or 10 days weighing a decision, each one comes with strings attached. With each option you choose, you’re saying ‘no’ to a different option. The value of what you do not select is called your opportunity cost. You keep reading

You’re breezing along the railroad track of life. Like the steel wheels on a train, your choices in life have almost totally reduced friction and enhanced your midlife journey. Before you arrive at the next station, you’re at the peak of your career and in overall great health. Suddenly, where the steel meets the tracks, keep reading

Advances in medicine sometimes involve hybrid technologies, often with stunning results. Just as hybrid cars produce vehicles that offer the best of two worlds in one, integrating two different medical imaging technologies can accomplish the same goal. PET and MRI scans Combining Positron Emitting Tomography (PET) scanning with Magnetic Resonance Imaging (MRI) boosts the accuracy keep reading

I have written in the past about the problems with using prostate specific antigen (PSA) as a screening tool for prostate cancer. Virtually all men over age 40 know they should have a PSA blood test at their annual exam, yet few have a complete understanding of what it really says... keep reading

Fourteen months prior to the time of this writing, the world began locking down due to the emerging SARS-CoV-2 viral pandemic and the potentially deadly COVID illness it causes. We were all confused, and studies repeatedly show that normal screening for cancers such as breast, prostate and colorectal dropped significantly... keep reading

Proton beam therapy for prostate cancer has been struggling with insurance issues because it is significantly more costly than conventional radiation types, yet has not demonstrated better cancer control. However, in the minds of many patients, it offers a better chance at cure... keep reading